Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD?

3' education - Sep. 5, 2022 - Prof. Marco Valgimigli, MD, PhD - Lugano, Switzerland

Educational information

This video was recorded during the ESC Congress 2022 in Barcelona, Spain.

Faculty

Marco Valgimigli, MD, PhD - Cardiocentro Ticino Foundation, Lugano in Switzerland.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the PANTHER-study

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.